Article Details
Retrieved on: 2024-02-22 15:25:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
This article announces Daniel O'Day of Gilead Sciences as the new chair of the Pharmaceutical Research and Manufacturers of America (PhRMA), highlighting the biopharma industry's leadership changes and commitment to innovation and patient access to medicines.
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here